Latigo Biotherapeutics, Inc.: SCHEDULE 13G filed Aug 18, 2026

Form type

SCHEDULE 13G

Filing date

Aug 18, 2026

Accession number

0001193125-26-355798

Filer

Latigo Biotherapeutics, Inc. (CIK 2056611)